ABC | Volume 110, Nº3, March 2018

Editorial Oliveira & Ferreira Yellow fever and cardiovascular disease Arq Bras Cardiol. 2018; 110(3):207-210 1. Braack L, Gouveia de Almeida AP, Cornel AJ, Swanepoel R, de Jager C. Mosquito-borne arboviruses of African origin: review of key viruses and vectors. Parasit Vectors. 2018;11(1):29. 2. MotaMT,TerzianAC,SilvaML,EstofoleteC,NogueiraML.Mosquito-transmitted viruses–thegreatBrazilianchallenge.BrazJMicrobiol.2016;47Suppl1:38-50. 3. Colon-Gonzalez FJ, Peres CA, Steiner São Bernardo C, Hunter PR, Lake IR. After the epidemic: Zika virus projections for Latin America and the Caribbean. PLoS Negl Trop Dis. 2017;11(11):e0006007. 4. Azevedo Rdo S, Oliveira CS, Vasconcelos PF. Chikungunya risk for Brazil. Rev Saude Publica. 2015;49:58. 5. Hamrick PN, Aldighieri S, Machado G, Leonel DG, Vilca LM, Uriona S, et al. Geographicpatternsandenvironmentalfactorsassociatedwithhumanyellow fever presence in the Americas. PLoS Negl Trop Dis. 2017;11(9):e0005897. 6. Engelmann F, Josset L, Girke T, Park B, Barron A, Dewane J, et al. Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model. PLoS Negl Trop Dis. 2014;8(11):e3295. 7. Cong Y, McArthur MA, Cohen M, Jahrling PB, Janosko KB, Josleyn N, et al. Characterization of yellow fever virus infection of human and non-human primate antigen presenting cells and their interaction with CD4+ T cells. PLoS Negl Trop Dis. 2016;10(5):e0004709. 8. LloydW. The myocardium in yellow fever. Science. 1930;72(1853):18. 9. Thiruvengadam K, Kalyanasunderam V, Rajgopal J. Clinical and pathological studies on chikungunya fever in Madras City. Indian J Med Res. 1965;53(8):729-44. 10. NagaratnamN, Siripala K, de Silva N. Arbovirus (dengue type) as a cause of acute myocarditis and pericarditis. Br Heart J. 1973;35(2):204-6. 11. Alvarez MF, Bolívar-Mejía A, Rodriguez-Morales AJ, Ramirez-Vallejo E. Cardiovascular involvement and manifestations of systemic Chikungunya virus infection: a systematic review. Version 2. F1000Res. 2017 Mar 29 [revised 2017 May 2];6:390. 12. Miranda CH, BorgesMde C, Schmidt A, Pazin-Filho A, Rossi MA, Ramos SG, et al. A case presentation of a fatal dengue myocarditis showing evidence for dengue virus-induced lesion. Eur Heart J Acute Cardiovasc Care. 2013;2(2):127-30. 13. Minhas AM, Nayab A, Iyer S, NarmeenM, Fatima K, MuhammadMS, et al. Association of Zika virus with myocarditis, heart failure, and arrhythmias: a literature review. Cureus. 2017;9(6):e1399. 14. Brasil. Minist rio da Saúde. Febre amarela : guia para profissionais de saúde. Secretaria de Aten ão a Saúde. Brasília; 2017. 67 p. 15. Brasil. Minist rio da Saúde. Dengue: Secretaria de Vigilância em Saúde, Diretoria T cnica de Gestão. 4ª. ed. Brasília; 2013. 80 p. 16. Zapata JC, Cox D, Salvato MS. The role of platelets in the pathogenesis of viral hemorrhagic fevers. PLoS Negl Trop Dis. 2014;8(6):e2858. 17. Valgimigli M, Bueno H, Byrne R, Collet JP, Costa F, Jeppsson A, et al; ESC Scientific Document Group ; ESC Committee for Practice Guidelines (CPG) ; ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213-60. 18. Jondeau G, Milleron O. Beta-blockers in acute heart failure: do they cause harm? JACC Heart Fail. 2015;3(8):654-6. References This is an open-access article distributed under the terms of the Creative Commons Attribution License 210